Kamil Ali-Jackson's Net Worth

$3.06 Million

Estimate Recalculated Jul 5, 2024 01:47PM EST

Who is Kamil Ali-Jackson?

Kamil Ali-Jackson has an estimated net worth of $3.06 Million. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, Aclaris Therapeutics, Inc., and PDS Biotechnology Corp.

SEC CIK

Kamil Ali-Jackson's CIK is 0001654337

Past Insider Trading and Trends

2021 was Kamil Ali-Jackson's most active year for acquiring shares with 14 total transactions. Kamil Ali-Jackson's most active month to acquire stocks was the month of November. 2021 was Kamil Ali-Jackson's most active year for disposing of shares, totalling 30 transactions. Kamil Ali-Jackson's most active month to dispose stocks was the month of April. 2021 saw Kamil Ali-Jackson paying a total of $797,328.56 for 394,956 shares, this is the most they've acquired in one year. In 2021 Kamil Ali-Jackson cashed out on 261,977 shares for a total of $2,959,112.97, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $1.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+57.14%
25K
—
—
68.75K
May 25
Form 4
+133.33%
25K
—
—
43.75K
May 26
Form 4
∞
18.75K
—
—
18.75K
May 20
Form 4
—
0
—
—
0
Dec 16
Form 3
—
0
—
—
0
No matching records found

Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.13

Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+39.69%
45.52K
—
—
160.21K
Jan 3
Form 4
-6.14%
-7.50K
—
—
114.7K
Mar 11
Form 4
-7.21%
-9.49K
$21.96
-$208,420.59
122.2K
Scheduled
Jun 3
Form 4
-8.31%
-11.93K
$22.10
-$996,963.10
131.69K
Scheduled
Jun 1 - Jun 2
Form 4
—
0
$17.06
-$261,210.40
143.62K
Scheduled
May 6 - May 7
Form 4
—
0
$17.37
-$604,018.47
143.62K
Scheduled
May 3 - May 5
Form 4
+13.40%
16.97K
$23.83
-$163,026.54
143.62K
Mar 1 - Mar 2
Form 4
+2.06%
2.56K
$21.35
-$28,139.30
126.65K
Feb 1
Form 4
+1.01%
1.24K
$4.59
-$2,285.82
124.09K
Dec 15
Form 4
+23.84%
23.65K
$1.32
-$12,584.88
122.85K
Jun 1
Form 4
+14.28%
12.4K
$1.26
-$6,021.54
99.2K
Mar 2
Form 4
+3.04%
2.56K
$1.28
-$1,687.04
86.8K
Feb 3
Form 4
+0.96%
798
$1.81
-$501.37
84.25K
Dec 18
Form 4
+1.50%
1.24K
$1.80
-$894.60
83.45K
Dec 16
Form 4
—
0
—
—
0
Mar 1
Form 4
+3.22%
2.57K
$6.96
-$9,103.68
82.21K
Feb 1
Form 4
+0.97%
769
$6.30
-$1,927.80
79.64K
Dec 18
Form 4
+1.60%
1.24K
$7.31
-$3,603.83
78.88K
Dec 15
Form 4
-6.05%
-5.00K
$20.00
-$100,000.00
77.64K
Scheduled
Jun 11 - Jun 12
Form 4
-10.79%
-10.00K
$20.00
-$200,000.00
82.64K
Scheduled
May 18
Form 4
+5.66%
4.96K
$18.10
-$35,729.40
92.64K
May 7
Form 4
+11.46%
9.02K
—
—
87.68K
Mar 16
Form 4
—
0
—
—
0
Feb 1
Form 4
+2.55%
1.95K
$24.19
-$20,656.45
78.66K
Dec 15 - Dec 18
Form 4
+0.98%
748
$31.25
-$10,218.75
76.7K
Dec 18
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
$11.68
-$79,452.72
75.96K
Scheduled
Oct 26
Form 4
—
0
$12.69
-$44,073.54
75.96K
Scheduled
Sep 26 - Sep 28
Form 4
+274.38%
55.67K
—
—
75.96K
Sep 15
Form 4
-15.56%
-3.74K
$20.35
-$76,068.30
20.29K
Scheduled
Aug 26
Form 4
—
0
—
—
0
Dec 18
Form 4
+18.42%
3.74K
—
—
24.03K
Oct 13
Form 3
—
0
—
—
0
No matching records found

PDS Biotechnology Corp (PDSB) Snapshot price: $5.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jul 14
Form 4
—
0
—
—
0
Jun 28
Form 4
∞
11.76K
$8.50
$99,994.00
11.76K
Jun 15 - Jun 17
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Feb 21
Form 3
—
0
—
—
0
No matching records found